Literature DB >> 11817186

Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management.

T Asrat1.   

Abstract

The recent increase in knowledge about infection and preterm delivery has engendered many new questions and should make us rethink our long held beliefs and management strategies. Although this article focused primarily on infection as an important factor in the pathogenesis of PPROM, multiple other causes do exist. The various serologic and amniotic fluid assays that can identify activation of the host immune and inflammatory responses as a consequence of the microbial invasion of the amniotic cavity detailed in the preceding paragraphs are very promising but not yet available for clinical use. These tests identify the fetus in the early stages of an infectious process, before the full clinical manifestations of chorioamnionitis. Should such fetuses be treated with antibiotics in an effort to sterilize the amniotic cavity? Should patients with documented microbial invasion be delivered immediately or is there room for a more conservative management with aggressive antibiotic in utero treatment, altering the natural course of PPROM, avoiding extremely preterm deliveries? Certainly many questions remain unanswered. Continuing the search for information on the relationship between infection and PPROM can only add hope to one day finding an option for prevention, because many and probably most cases of PPROM are apparently caused by infection, and the opportunity for preventing this problem most probably lies here.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817186     DOI: 10.1016/s0095-5108(03)00074-5

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  8 in total

1.  Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response.

Authors:  Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Zhong Dong; Nikolina Docheva; Alicia Martinez-Varea; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

Review 2.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

3.  Tissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture system.

Authors:  Veronica Zaga-Clavellina; Martha Ruiz; Pilar Flores-Espinosa; Rodrigo Vega-Sanchez; Arturo Flores-Pliego; Guadalupe Estrada-Gutierrez; Irma Sosa-Gonzalez; Iyari Morales-Méndez; Mauricio Osorio-Caballero
Journal:  Reprod Biol Endocrinol       Date:  2012-09-03       Impact factor: 5.211

4.  Tissue-specific human beta-defensins (HBD)1, HBD2, and HBD3 secretion from human extra-placental membranes stimulated with Escherichia coli.

Authors:  Guadalupe Garcia-Lopez; Pilar Flores-Espinosa; Veronica Zaga-Clavellina
Journal:  Reprod Biol Endocrinol       Date:  2010-12-01       Impact factor: 5.211

5.  Use of Vaginal Dinoprostone (PGE2) in Patients with Premature Rupture of Membranes (PROM) Undergoing Induction of Labor: A Comparative Study.

Authors:  Nuria López-Jiménez; Fiamma García-Sánchez; Rafael Hernández Pailos; Valentin Rodrigo-Álvaro; Ana Pascual-Pedreño; María Moreno-Cid; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

6.  Related factors and adverse neonatal outcomes in women with preterm premature rupture of membranes complicated by histologic chorioamnionitis.

Authors:  Ailan Xie; Wenwen Zhang; Miaomiao Chen; Yuhuan Wang; Ying Wang; Qingfeng Zhou; Xueqiong Zhu
Journal:  Med Sci Monit       Date:  2015-02-03

7.  Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine.

Authors:  Zoë L Vincent; Murray D Mitchell; Anna P Ponnampalam
Journal:  Reprod Biol Endocrinol       Date:  2015-12-21       Impact factor: 5.211

8.  Positive maternal C-reactive protein predicts neonatal sepsis.

Authors:  Ji Hyun Jeon; Ran Namgung; Min Soo Park; Koo In Park; Chul Lee
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.